STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/25068f9f9585e6519851f2a246170974c5f74a32"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a new policy for compounding peptides, a PBM disclosure rule, and more"></iframe>